• Peet FY26 earnings: Profit and dividend surge on record sales

    Magnifying glass in front of an open newspaper with paper houses.

    The Peet Ltd (ASX: PPC) share price is in focus after the company delivered record earnings for FY26, on the back of strong sales and robust performance in Western Australia and Queensland.

    What did Peet report?

    • Net operating profit of $103.4 million, up 77% on the prior year
    • Operating earnings per share of 22.1 cents, also up 77%
    • Total FY26 fully franked dividends of 13.0 cents per share, up 68%
    • Revenue rose 3% to $450.2 million
    • EBITDA grew 54% to $162.8 million, with margin expanding to 36%
    • Contracts on hand increased 39% to $851 million

    What else do investors need to know?

    Peet sold 2,996 lots during the year, up 8%, while settlements rose to 2,665 lots. The group’s development pipeline remains extensive, comprising more than 26,400 lots across 37 projects with an estimated end value of $11.5 billion.

    Gearing reduced to 24.8%, while the company maintained a strong balance sheet with net debt decreased to $201.3 million. Peet also increased its activated pipeline to 80%, offering solid visibility for future earnings.

    What did Peet management say?

    Chief Executive Officer Brett Fullarton said:

    FY26 represents another exceptional year for Peet, with record operating profit, significant earnings growth and increased returns to shareholders. The result reflects the strength of our national portfolio, favourable conditions across several of our key markets and the disciplined execution of our strategy.

    What’s next for Peet?

    Peet enters FY27 in a strong financial position with $851 million in contracts on hand and a highly activated project portfolio. The company expects to benefit from ongoing demand in Western Australia, Queensland, and South Australia, while remaining alert to improvements in Victoria and NSW/ACT.

    Management highlighted positive structural factors for the residential housing sector, including population growth, limited supply, and policy support for buyers. Peet intends to leverage its pipeline and balance sheet strength to pursue growth opportunities, mindful of settlement timing and broader market conditions.

    Peet share price snapshot

    Over the past 12 months, Peet shares have risen 3%, slightly outperforming the All Ordinaries Index (ASX: XAO), which has increased 1% over the same period.

    View Original Announcement

    The post Peet FY26 earnings: Profit and dividend surge on record sales appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Peet right now?

    Before you buy Peet shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Peet wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

  • Tivan gets green light for maiden drilling at Sandover Fluorite Project

    Two miners laughing and having fun while using smart phone during their coffee break.

    The Tivan Ltd (ASX: TVN) share price is in focus after the company received final approvals to commence its maiden drilling program at Walshy’s Wall within the Sandover Fluorite Project. High-grade manganese samples up to 44.8% and fluorite at 98.4% CaF₂ were previously identified.

    What did Tivan report?

    • Regulatory approval secured from the Northern Territory Government for drilling at Walshy’s Wall
    • Sacred Site Clearance Certificate received from the Central Land Council
    • Maiden staged program planned: 31 reverse circulation drill holes, with nine priority holes commencing October
    • Rock chip sampling returned manganese grades up to 44.8% Mn and fluorite up to 98.4% CaF₂
    • Elevated copper (up to 0.5%), beryllium (up to 50ppm) and tungsten (up to 0.12%) levels identified

    What else do investors need to know?

    Tivan’s drilling program at Walshy’s Wall represents the company’s first systematic test of this recently discovered manganese-barite gossan. The approvals bring the drill program within the environmental and cultural heritage requirements of the Sandover project and reflect the support of both the Northern Territory Government and Traditional Owners.

    The drill campaign is set to target the strongest geochemical anomalies identified during recent field work. Stage One drilling will focus on the most prospective sections, while Stage Two may expand based on initial results.

    What did Tivan management say?

    Executive Chairman Grant Wilson said:

    We are very pleased to have secured these approvals on a timely basis, that will enable Tivan’s geology team to complete a maiden drilling program at Walshy’s Wall before the summer heat arrives. We extend sincere thanks to the Northern Territory Government and the Central Land Council.

    What’s next for Tivan?

    Tivan’s team is preparing to mobilise for the Stage One drilling, which will commence in October. This first stage will help the company determine if the strong surface mineralisation is mirrored at depth.

    The results from the initial drilling will guide the potential rollout of Stage Two, testing the broader scale and continuity of the mineralised system. Tivan aims to unlock further value at the Sandover project and progress exploration efficiently within approved guidelines.

    Tivan share price snapshot

    Over the past 12 months, Tivan shares have risen 140%, outperforming the All Ordinaries Index (ASX: XAO), which has risen 1% over the same period.

    View Original Announcement

    The post Tivan gets green light for maiden drilling at Sandover Fluorite Project appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Tivan Ltd right now?

    Before you buy Tivan Ltd shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Tivan Ltd wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

  • Buy, hold, sell: Judo Capital, Healius, BHP shares

    Woman and man at work looking at data on a tablet at work.

    S&P/ASX 200 Index (ASX: XJO) shares are up 0.74% to 9,168.7 points on Tuesday.

    All 11 market sectors of the ASX 200 are in the green today.

    Healthcare leads the pack, up 1.1%, extending its impressive recent rebound.

    ARB Corporation Ltd (ASX: ARB) is the fastest riser of the ASX 200 today, up 18% on its FY26 report.

    Meanwhile, Morgans has issued some new notes on three ASX shares.

    They include BHP Group Ltd (ASX: BHP) shares, which hit a new all-time high today.

    Let’s take a look.

    Judo Capital Holdings Ltd (ASX: JDO)

    The Judo Capital share price is $1.03, up 6.4% today and down 42% over 12 months. 

    Judo Capital shares are the fourth fastest riser on the local bourse despite no significant announcements today.

    Morgans has a buy rating on this ASX bank share after its FY26 results.

    The broker said: 

    FY26 PBT landed towards the top end of the revised guidance range and FY27 guidance was reaffirmed offering strong earnings growth.

    EPS forecasts moderated 2-6%.

    The broker shaved its 12-month price target from $1.47 to $1.42.

    This suggests a potential 40% upside ahead.

    Healius Ltd (ASX: HLS)

    The Healius share price is 43 cents, down 0.7% today and down 49% over 12 months. 

    Since the healthcare sector began its long-awaited rebound on 3 June, Healius shares have soared 29%.

    Morgans has a hold rating on this ASX 200 healthcare share following its FY26 report.

    The broker said: 

    FY26 results were mixed, with revenue and underlying EBITDA broadly in line, but underlying EBIT 5% below consensus and at the bottom of guidance, reflecting still-thin Pathology margins.

    Encouragingly, Pathology EBIT margin improved materially in 2H, while labour costs fell 2.9% and group cost growth was contained.

    Agilex was again a clear positive, with revenue and earnings growth ahead of expectations.

    While FY27 EBIT guidance of A$39.7m is broadly in line with expectations, the T27 target for mid-to-high single-digit EBIT margins was extended by c18 months to Dec-28, leaving us cautious on the pace and sustainability of earnings leverage.

    The broker increased its price target to 43 cents, implying the stock is fully valued.

    BHP Group Ltd (ASX: BHP)

    The BHP share price is $67.93, up 1.2% today and up 57% over 12 months. 

    BHP shares reached a new record of $68.22 in earlier trading on Tuesday.

    Morgans downgraded BHP shares to a sell call after its FY26 report on 18 August.

    The broker explained: 

    A solid FY26 result, with an upsized final dividend of US 99cps, against a share price that appears to already factor in more upside, we lower our rating to TRIM.

    Metal prices were a key driver, but BHP also maintained a solid operating performance on controllable factors against a tough backdrop in FY26.

    The broker reduced its 12-month price target from $59.80 to $55.30.

    This suggests a potential 18% downside ahead.

    The post Buy, hold, sell: Judo Capital, Healius, BHP shares appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Judo Capital right now?

    Before you buy Judo Capital shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Judo Capital wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended ARB Corporation. The Motley Fool Australia has recommended ARB Corporation and BHP Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Financial statement inaccuracy

  • PFE | Pfizer and German partner BioNTech SE said Tuesday they’ve begun delivering doses of their coronavirus vaccine to US candidates with trials in Germany already underway.

  • PFE | Pfizer and German Parker BioNTech SE have begun delivering doses of their coronavirus vaccine for human testing US, trials in Germany already underway.

  • The performance outlook of tech companies.